Aquaporin-4 mediated glymphatic dysfunction and neuroinflammatory signaling in neurodegenerative disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review of mechanistic pathways and preclinical evidence with no original human data or systematic review methodology.
PubMed 42606899 · doi:10.1080/00207454.2026.2719591
What was done
This narrative review synthesizes literature concerning aquaporin channels (primarily AQP4 at astrocyte endfeet) in the central nervous system, focusing on their mechanistic roles in fluid homeostasis, blood-brain barrier maintenance, glymphatic solute clearance (such as amyloid-beta), and neuroinflammatory signaling cascades involving NF-kappaB and p38 MAPK.
What was found
The abstract presents no quantitative data or specific numerical metrics. Qualitatively, it reports that altered expression and loss of polarity in aquaporin channels impair glymphatic clearance, promote toxic protein accumulation, disrupt the blood-brain barrier, and exacerbate neuroinflammation in Alzheimer's disease, Parkinson's disease, epilepsy, and ischemic stroke.
Why it matters
It outlines the mechanistic basis for how AQP4 polarity disruption links fluid clearance failure to neuroinflammation, highlighting AQP4 as a potential therapeutic target in neurodegenerative diseases.
Limits
As a narrative review, it lacks systematic search methodology and quantitative meta-analytic pooling. No original human clinical trial data or quantitative effect sizes are provided, with findings grounded primarily in preclinical models.